Natural products often provide lead scaffolds for the development of therapeutics, but complexity of their synthesis can limit the discovery of improved analogues. Pharmacophore-directed retrosynthesis aims to accelerate the building of a structure–activity relationship profile of a natural product, aiming to identifying a simplified lead.
References
Wender, P. A. Nat. Prod. Rep. 31, 433–440 (2014).
Wilson, R. M. & Danishefsky, S. J. J. Org. Chem. 71, 8329–8351 (2006).
Schreiber, S. L. Science 287, 1964–1969 (2000).
Romo, D. et al. Nat. Chem. https://doi.org/10.1038/s41557-019-0230-0 (2019).
Mayol, L., Piccialli, V. & Sica, D. Tetrahedron Lett. 26, 1357–1360 (1985).
Sanchez, J. A. et al. Pharmacol. Res. 107, 407–414 (2016).
Leiros, M. et al. Neuropharmacology 93, 285–293 (2015).
Allred, T. K., Manoni, F. & Harran, P. G. Chem. Rev. 117, 11994–12051 (2017).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hudlicky, J.R., Sulikowski, G.A. Simple start for complex products. Nat. Chem. 11, 297–298 (2019). https://doi.org/10.1038/s41557-019-0241-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41557-019-0241-x
- Springer Nature Limited